Labcorp buys select BioReference Health assets from OPKO

Labcorp agreed to acquire select assets of BioReference Health from parent OPKO Health. The package covers clinical, women's health, urology and corrections testing businesses, more than 80 patient service centers, and the FDA-approved 4Kscore prostate cancer test. Terms were not disclosed.

Why it matters: OPKO keeps shrinking its lab business, while Labcorp adds specialty testing and patient access points.